CollPlant Biotechnologies Ltd. (CLGN)
NASDAQ: CLGN · Real-Time Price · USD
4.130
+0.220 (5.63%)
At close: Oct 14, 2026, 4:00 PM EDT
3.939
-0.191 (-4.63%)
After-hours: Oct 14, 2026, 7:56 PM EDT
CollPlant Biotechnologies Market Cap
CollPlant Biotechnologies has a market cap or net worth of $7.81 million as of October 14, 2026. It is the 43,233rd most valuable company in the world and the 5,822nd biggest in the United States. Its market cap has decreased by 72.58% in one year.
Market Cap
7.81M
Enterprise Value
7.91M
1-Year Change
-72.58%
Global Rank
Country Rank
#5,822 United States
Category
ChartMarket Cap Chart
Since May 14, 2015, CollPlant Biotechnologies's market cap has decreased from $29.72M to $7.81M, a decrease of -73.72%. That is a compound annual growth rate of -11.04%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 14, 2026 | 7.74M | -56.74% |
| Dec 31, 2025 | 17.89M | -56.62% |
| Dec 31, 2024 | 41.24M | -43.65% |
| Dec 29, 2023 | 73.18M | -21.52% |
| Dec 30, 2022 | 93.25M | -46.69% |
| Dec 31, 2021 | 174.91M | 147.10% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 22, 2017 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Niki BioSolutions | 7.96M |
| CNS Pharmaceuticals | 7.89M |
| Exicure | 7.72M |
| Aprea Therapeutics | 7.67M |
| CalciMedica | 7.51M |
| Soligenix | 7.34M |
| XTL Biopharmaceuticals | 7.07M |
| FibroBiologics | 6.92M |